Literature DB >> 18060647

The expression of interleukin-22 and S100A7, A8, A9 mRNA in patients with psoriasis vulgaris.

Houjun Liu1, Kun Huang, Yan Wu, Nengxing Lin, Jiawen Li, Yating Tu.   

Abstract

In order to study the expression of interleukin-22 (IL-22) and S100A7, A8, A9 mRNA in the skin lesions of patients with psoriasis vulgaris and their relationship, the biopsies were taken from skin lesions in 35 patients with psoriasis vulgaris and the skin of 16 normal controls, and the expression levels of IL-22 and S100A7, A8 and A9 mRNA were detected by semi-quantitative RT-PCR. The results showed that (1) IL-22 and S100A8, A9 mRNA were positively expressed in the psoriatic skin lesions but negatively expressed in the normal controls; The expression level of S100A7 was (1.133+/-0.040) in the psoriatic skin lesions, significantly higher than that in the normal controls (0.744+/-0.037, P<0.01). (2) There were significantly positive correlations between the expression of IL-22/S100A7 mRNA, IL-22/S100A8 mRNA, IL-22/S100A9 mRNA in the psoriasis vulgaris (r(1)=0.543, r (2)=0.774, r(3)=0.621, P<0.01). It was concluded that IL-22 and S100A7, A8, A9 might play important roles in the occurrence and progression of psoriasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18060647     DOI: 10.1007/s11596-007-0533-z

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  10 in total

1.  Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9.

Authors:  L Dumoutier; J Louahed; J C Renauld
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

2.  Psoriasin: a novel chemotactic protein.

Authors:  T Jinquan; H Vorum; C G Larsen; P Madsen; H H Rasmussen; B Gesser; M Etzerodt; B Honoré; J E Celis; K Thestrup-Pedersen
Journal:  J Invest Dermatol       Date:  1996-07       Impact factor: 8.551

3.  The Ca2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes.

Authors:  I S Thorey; J Roth; J Regenbogen; J P Halle; M Bittner; T Vogl; S Kaesler; P Bugnon; B Reitmaier; S Durka; A Graf; M Wöckner; N Rieger; A Konstantinow; E Wolf; A Goppelt; S Werner
Journal:  J Biol Chem       Date:  2001-07-19       Impact factor: 5.157

4.  Acinar cells of the pancreas are a target of interleukin-22.

Authors:  S Aggarwal; M H Xie; M Maruoka; J Foster; A L Gurney
Journal:  J Interferon Cytokine Res       Date:  2001-12       Impact factor: 2.607

5.  Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor.

Authors:  L Dumoutier; E Van Roost; D Colau; J C Renauld
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

6.  Cutting edge: immune cells as sources and targets of the IL-10 family members?

Authors:  Kerstin Wolk; Stefanie Kunz; Khusru Asadullah; Robert Sabat
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

7.  IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes.

Authors:  Katia Boniface; François-Xavier Bernard; Martine Garcia; Austin L Gurney; Jean-Claude Lecron; Franck Morel
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

Review 8.  S100 proteins in the epidermis.

Authors:  Richard L Eckert; Ann-Marie Broome; Monica Ruse; Nancy Robinson; David Ryan; Kathleen Lee
Journal:  J Invest Dermatol       Date:  2004-07       Impact factor: 8.551

9.  IL-22 increases the innate immunity of tissues.

Authors:  Kerstin Wolk; Stefanie Kunz; Ellen Witte; Markus Friedrich; Khusru Asadullah; Robert Sabat
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

10.  Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex ("epidermal differentiation complex") on human chromosome 1q21.

Authors:  D Mischke; B P Korge; I Marenholz; A Volz; A Ziegler
Journal:  J Invest Dermatol       Date:  1996-05       Impact factor: 8.551

  10 in total
  9 in total

1.  IL-36γ (IL-1F9) is a biomarker for psoriasis skin lesions.

Authors:  Angelo Massimiliano D'Erme; Dagmar Wilsmann-Theis; Julia Wagenpfeil; Michael Hölzel; Sandra Ferring-Schmitt; Sonja Sternberg; Miriam Wittmann; Bettina Peters; Andreas Bosio; Thomas Bieber; Joerg Wenzel
Journal:  J Invest Dermatol       Date:  2014-12-19       Impact factor: 8.551

Review 2.  Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.

Authors:  Gregory F Sonnenberg; Lynette A Fouser; David Artis
Journal:  Nat Immunol       Date:  2011-05       Impact factor: 25.606

3.  Interleukin 22 inhibits intracellular growth of Mycobacterium tuberculosis by enhancing calgranulin A expression.

Authors:  Rohan Dhiman; Sambasivan Venkatasubramanian; Padmaja Paidipally; Peter F Barnes; Amy Tvinnereim; Ramakrishna Vankayalapati
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

Review 4.  Novel insights into the role of S100A8/A9 in skin biology.

Authors:  Claus Kerkhoff; Andreas Voss; Thomas E Scholzen; Michelle M Averill; Kurt S Zänker; Karin E Bornfeldt
Journal:  Exp Dermatol       Date:  2012-08-09       Impact factor: 3.960

5.  Keratinocyte but not endothelial cell-specific overexpression of Tie2 leads to the development of psoriasis.

Authors:  Julie A Wolfram; Doina Diaconu; Denise A Hatala; Jessica Rastegar; Dorothy A Knutsen; Abigail Lowther; David Askew; Anita C Gilliam; Thomas S McCormick; Nicole L Ward
Journal:  Am J Pathol       Date:  2009-04       Impact factor: 4.307

Review 6.  Targeting interleukin-22 in psoriasis.

Authors:  Ji-Qing Hao
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

7.  Observational study on Swedish plaque psoriasis patients receiving narrowband-UVB treatment show decreased S100A8/A9 protein and gene expression levels in lesional psoriasis skin but no effect on S100A8/A9 protein levels in serum.

Authors:  Albert Duvetorp; Jan Söderman; Malin Assarsson; Marita Skarstedt; Åke Svensson; Oliver Seifert
Journal:  PLoS One       Date:  2019-03-13       Impact factor: 3.240

8.  RIPK1 downregulation enhances neutrophil extracellular traps in psoriasis.

Authors:  Xinyu Meng; Ruru Guo; Chaofan Fan; Yixuan Li; Xuesong Liu; Xiaoxiang Chen; Liangjing Lu
Journal:  Postepy Dermatol Alergol       Date:  2022-02-28       Impact factor: 1.837

9.  Evidence for biochemical barrier restoration: Topical solenopsin analogs improve inflammation and acanthosis in the KC-Tie2 mouse model of psoriasis.

Authors:  Jack L Arbiser; Ron Nowak; Kellie Michaels; Yuliya Skabytska; Tilo Biedermann; Monica J Lewis; Michael Y Bonner; Shikha Rao; Linda C Gilbert; Nabiha Yusuf; Isabella Karlsson; Yi Fritz; Nicole L Ward
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.